Form 8-K - Current report:
SEC Accession No. 0001367644-25-000004
Filing Date
2025-01-08
Accepted
2025-01-08 17:12:07
Documents
37
Period of Report
2024-12-12
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K ebs-20241212.htm   iXBRL 8-K 32874
2 EX-10.1 cyfendusmod.htm EX-10.1 8008
3 EX-10.2 biothraxmod.htm EX-10.2 7922
4 EX-99.1 pressrelease_121624.htm EX-99.1 15711
5 EX-99.2 pressrelease_010825.htm EX-99.2 16631
9 biothraxmod001.jpg GRAPHIC 254003
10 biothraxmod002.jpg GRAPHIC 106990
11 biothraxmod003.jpg GRAPHIC 92022
12 biothraxmod004.jpg GRAPHIC 55586
13 cyfendusmod001.jpg GRAPHIC 242771
14 cyfendusmod002.jpg GRAPHIC 82385
15 cyfendusmod003.jpg GRAPHIC 150406
16 cyfendusmod004.jpg GRAPHIC 200226
17 cyfendusmod005.jpg GRAPHIC 204394
18 cyfendusmod006.jpg GRAPHIC 143854
19 cyfendusmod007.jpg GRAPHIC 163335
20 cyfendusmod008.jpg GRAPHIC 197445
21 cyfendusmod009.jpg GRAPHIC 203099
22 cyfendusmod010.jpg GRAPHIC 276048
23 cyfendusmod011.jpg GRAPHIC 262584
24 cyfendusmod012.jpg GRAPHIC 184243
25 cyfendusmod013.jpg GRAPHIC 161075
26 cyfendusmod014.jpg GRAPHIC 96868
27 image.jpg GRAPHIC 7489
28 imagea.jpg GRAPHIC 7489
  Complete submission text file 0001367644-25-000004.txt   4485329

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT ebs-20241212.xsd EX-101.SCH 1848
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT ebs-20241212_lab.xml EX-101.LAB 22804
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT ebs-20241212_pre.xml EX-101.PRE 13102
39 EXTRACTED XBRL INSTANCE DOCUMENT ebs-20241212_htm.xml XML 2819
Mailing Address 300 PROFESSIONAL DR GAITHERSBURG MD 20879
Business Address 300 PROFESSIONAL DR GAITHERSBURG MD 20879 240-631-3200
Emergent BioSolutions Inc. (Filer) CIK: 0001367644 (see all company filings)

EIN.: 141902018 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33137 | Film No.: 25519281
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)